<DOC>
	<DOCNO>NCT01465568</DOCNO>
	<brief_summary>The purpose study study efficacy denosumab , new drug , treatment osteoporosis patient use bisphosphonates .</brief_summary>
	<brief_title>Denosumab Current Users Bisphosphonates Glucocorticoid-induced Osteoporosis</brief_title>
	<detailed_description>There data use denosumab steroid induce osteoporosis . Postmenopausal woman chronic use Glucocorticoid ( GCs ) high-risk osteoporotic fracture . Despite bisphosphonate treatment , certain proportion high-risk patient use chronic GCs either achieve satisfactory gain bone mineral density ( BMD ) develop new fragility fracture . Thus , potent osteoporosis treatment necessary subgroup patient . This prompt current study aim examine efficacy denosumab current user oral bisphosphonates Glucocorticoid-induced Osteoporosis ( GIOP ) .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Denosumab</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>1 . Women adult men ( &gt; 18 year age ) various medical disease require longterm prednisolone treatment . Premenopausal woman plan pregnancy within 2 year study entry agree practice contraception 2year period . 2 . A daily dose prednisolone ( equivalent ) 2.5mg within 3 month study entry . 3 . Having receive oral bisphosphonate treatment least 2 year . 4 . Suboptimal response bisphosphonate treatment , define either one following : ( 1 ) failure lumbar spine , femoral neck total hip BMD value increase ; ( 2 ) value lumbar spine , femoral neck total hip BMD remain osteoporotic , ie . T score &lt; 2.5 Z score &lt; 2.0 ; ( 3 ) development new fragility vertebral nonvertebral fracture despite least 2 year ' treatment good compliance . 5 . Informed consent patient . 1 . Patients previous use denosumab teriparatide . 2 . Premenopausal woman plan pregnancy within 2 year study entry agree contraception within 2year period . 3 . Patients know bone disorder osteomalacia , renal osteodystrophy , hyperparathyroidism . 4 . Patients unexplained hypocalcemia . 5 . Patients serum creatinine level &gt; =200umol/L .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>denosumab</keyword>
	<keyword>RANKL</keyword>
	<keyword>glucocorticoid</keyword>
</DOC>